Jan Stampfuss

1.2k total citations · 1 hit paper
8 papers, 837 citations indexed

About

Jan Stampfuss is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Jan Stampfuss has authored 8 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 3 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in Jan Stampfuss's work include Vitamin K Research Studies (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Jan Stampfuss is often cited by papers focused on Vitamin K Research Studies (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Atrial Fibrillation Management and Outcomes (3 papers). Jan Stampfuss collaborates with scholars based in Germany and United States. Jan Stampfuss's co-authors include Wolfgang Mueck, Dagmar Kubitza, Michael Becka, Stephan Schwers, Stefan Heitmeier, Christoph Gerdes, Adrian Tersteegen, Susanne Roehrig, Volker Laux and Mayken Visser and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Leukocyte Biology and Clinical Pharmacokinetics.

In The Last Decade

Jan Stampfuss

8 papers receiving 821 citations

Hit Papers

Clinical Pharmacokinetic and Pharmacodynamic Profile of R... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Stampfuss Germany 7 628 391 142 71 66 8 837
Kan He United States 5 654 1.0× 440 1.1× 57 0.4× 73 1.0× 107 1.6× 8 797
Barbara Voith Germany 9 1.1k 1.8× 919 2.4× 230 1.6× 160 2.3× 114 1.7× 15 1.5k
Maximilian T. Lobmeyer United States 14 1.1k 1.8× 384 1.0× 98 0.7× 146 2.1× 136 2.1× 26 1.6k
Antonio Gómez‐Outes Spain 20 970 1.5× 738 1.9× 139 1.0× 233 3.3× 81 1.2× 47 1.5k
Ma Luisa Suárez‐Gea Spain 15 600 1.0× 506 1.3× 87 0.6× 137 1.9× 17 0.3× 26 931
Stefan Blech Germany 6 450 0.7× 289 0.7× 62 0.4× 126 1.8× 81 1.2× 8 771
Oriana Paoletti Italy 14 598 1.0× 429 1.1× 104 0.7× 75 1.1× 58 0.9× 27 910
Toby C. Trujillo United States 18 412 0.7× 326 0.8× 77 0.5× 189 2.7× 36 0.5× 62 853
A M H P van den Besselaar Netherlands 18 431 0.7× 271 0.7× 99 0.7× 158 2.2× 36 0.5× 53 865
Hildegard Stähle Germany 8 1.8k 2.9× 1.3k 3.3× 212 1.5× 268 3.8× 107 1.6× 8 2.1k

Countries citing papers authored by Jan Stampfuss

Since Specialization
Citations

This map shows the geographic impact of Jan Stampfuss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Stampfuss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Stampfuss more than expected).

Fields of papers citing papers by Jan Stampfuss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Stampfuss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Stampfuss. The network helps show where Jan Stampfuss may publish in the future.

Co-authorship network of co-authors of Jan Stampfuss

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Stampfuss. A scholar is included among the top collaborators of Jan Stampfuss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Stampfuss. Jan Stampfuss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Roehrig, Susanne, Eloísa Jiménez Núñez, Katharina Meier, et al.. (2023). Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. Journal of Medicinal Chemistry. 66(17). 12203–12224. 14 indexed citations
2.
Meibom, Daniel, Jutta Meyer, Karl D. Collins, et al.. (2023). BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α2B Antagonist. Journal of Medicinal Chemistry. 66(7). 4659–4670. 2 indexed citations
3.
Heitmeier, Stefan, Mayken Visser, Adrian Tersteegen, et al.. (2022). Pharmacological profile of asundexian, a novel, orally bioavailable inhibitor of factor XIa. Journal of Thrombosis and Haemostasis. 20(6). 1400–1411. 52 indexed citations
4.
Willmann, Stefan, Kirstin Thelen, Dagmar Kubitza, et al.. (2018). Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study. Thrombosis Journal. 16(1). 32–32. 41 indexed citations
5.
Mueck, Wolfgang, Stephan Schwers, & Jan Stampfuss. (2013). Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring. Thrombosis Journal. 11(1). 10–10. 129 indexed citations
6.
Mueck, Wolfgang, Jan Stampfuss, Dagmar Kubitza, & Michael Becka. (2013). Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban. Clinical Pharmacokinetics. 53(1). 1–16. 429 indexed citations breakdown →
7.
Stampfuss, Jan, Dagmar Kubitza, Michael Becka, & Wolfgang Mueck. (2013). The effect of food on the absorption and pharmacokinetics of rivaroxaban. International Journal of Clinical Pharmacology and Therapeutics. 51(7). 549–561. 160 indexed citations
8.
Stampfuss, Jan, et al.. (2008). Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis. Journal of Leukocyte Biology. 83(6). 1379–1381. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026